Publication of the securities note having obtained visa no. 17-297 of the AMF in connection with the capital increase of GenSight Biologics
(WorldNews France)

Press release Publication of the securities note having obtained visa no. 17-297 of the AMF in connection with the capital increase of GenSight Biologics Paris, June 23, 2017 -GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), ("GenSight Biologics" or the "Company") informs that the listing prospectus containing the 2016 registration document of the Company, registered with the Autorité des marchés financiers (the "AMF") on April 28, 2017 under number R.17-03, as well as the securities note containing a description of the listing prospectus having obtained the visa n°17-297 on June 23, 2017 are made available to the public within the...